You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • SAT0172 Establishing Margins to Demonstrate Equivalence in Efficacy for Biosimilar Clinical Trials in Rheumatoid Arthritis Patients: A Meta-Analysis Approach

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0172 Establishing Margins to Demonstrate Equivalence in Efficacy for Biosimilar Clinical Trials in Rheumatoid Arthritis Patients: A Meta-Analysis Approach

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hua S, Barker K, Qu P, et al
SAT0172 Establishing Margins to Demonstrate Equivalence in Efficacy for Biosimilar Clinical Trials in Rheumatoid Arthritis Patients: A Meta-Analysis Approach
Annals of the Rheumatic Diseases 2015;74:716.